Skip to content

BREPHAR

Absorbed by MULTIPHARMA on 13-06-2024 KBO/BCE: BE 0875.406.885

Last board

2 directors, 1 auditor, last change in 2023
Director
since 02-10-2023 term until 14-06-2029
listed in the 2023 annual accounts, filed on 24-07-2024
Director (not named in the articles)
appointed by deed of 04-10-2023
Statutory auditor, permanent representative
appointed by deed of 19-10-2023
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 04-10-2023

Office holders in the KBO →

Mandates through the years

3 names, the dashed line is today

Director (not named in the articles)

Director

Statutory auditor
BoardRest of the term
Mandates as a list
    • Director (not named in the articles), from 30-07-2005 to date
    • Director, from 02-10-2023 to date
    • Statutory auditor, from 02-10-2023 to date
With Starter you also see 3 former office holders in the mandate history. See the plans →

Control

BREPHAR was absorbed by on 13-06-2024.

Capital

Contribution
€12,400
Source
2023 annual accounts

Articles of association

Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
deed of 04-10-2023 (in Dutch)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Thursday of June at 17:00
deed of 04-10-2023 (in Dutch)
Custody of recordsThe books and records are kept for at least five years after liquidation. The articles set where.
Siège de la Société Absorbante, livres et documents de la Société Absorbée
deed of 11-07-2024 (in French)

Shareholders

Owners 0

BREPHAR was absorbed by on 13-06-2024.
Former owners (1)
  • Sourcedeed 11-07-2024deed 11-07-2024
    100%

Capital transactions

Shareholders according to the deeds
Stated in the deed deed of 11-07-2024 ↗
  • all shares
Capital over time
  1. 04-10-2023 Converted to unavailable equity

Next steps